Cargando…

Answer to Cadiou et al. “SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?”. Joint Bone Spine 2021;88:105282

Detalles Bibliográficos
Autores principales:	Manzo, Ciro, Castagna, Alberto, Natale, Maria, Ruotolo, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française de rhumatologie. Published by Elsevier Masson SAS. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483980/ https://www.ncbi.nlm.nih.gov/pubmed/34601111 http://dx.doi.org/10.1016/j.jbspin.2021.105284

Ejemplares similares

Liver involvement in polymyalgia rheumatica and giant cell arteritis
por: Hysa, Elvis, et al.
Publicado: (2020)

Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis
por: Manzo, Ciro, et al.
Publicado: (2021)

Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?
por: Manzo, Ciro, et al.
Publicado: (2021)

SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150
por: Cadiou, Simon, et al.
Publicado: (2022)

Relapse of polymyalgia rheumatica after a fall
por: Manzo, Ciro, et al.
Publicado: (2017)

Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set
por: Manzo, Ciro, et al.
Publicado: (2016)

Widespread headache as the first clinical manifestation of giant cell arteritis in patients affected by polymyalgia rheumatica
por: Manzo, Ciro
Publicado: (2016)

Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)

Messages from the history of polymyalgia rheumatica
por: Manzo, Ciro
Publicado: (2021)

Polymyalgia rheumatica as uncommon adverse event following immunization with COVID‐19 vaccine: A case report and review of literature
por: Manzo, Ciro, et al.
Publicado: (2021)

Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
por: Manzo, Ciro, et al.
Publicado: (2021)

Is the absence of prolonged morning stiffness at the time of diagnosis of polymyalgia rheumatica a paraneoplastic warning?
por: Manzo, Ciro, et al.
Publicado: (2022)

Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update
por: Manzo, Ciro, et al.
Publicado: (2023)

Polymyalgia Rheumatica in Association with Remitting Seronegative Sinovitis with Pitting Edema: a Neoplastic Warning
por: Manzo, Ciro, et al.
Publicado: (2017)

Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature
por: Manzo, Ciro, et al.
Publicado: (2022)

Optimal management of giant cell arteritis and polymyalgia rheumatica
por: Charlton, Rodger
Publicado: (2012)

Genetic epidemiology: Giant cell arteritis and polymyalgia rheumatica
por: Gonzalez-Gay, Miguel A
Publicado: (2001)

Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update
por: Nesher, Gideon, et al.
Publicado: (2016)

Polymyalgia rheumatica and cancer: surveillance duration and other points to ponder
por: Manzo, Ciro, et al.
Publicado: (2023)

Diagnosis of polymyalgia rheumatica in primary health care: favoring and confounding factors – a cohort study
por: Manzo, Ciro, et al.
Publicado: (2018)

Subjective sleep disturbances at the time of diagnosis in patients with polymyalgia rheumatica and in patients with seronegative elderly-onset rheumatoid arthritis. A pilot study
por: Manzo, Ciro, et al.
Publicado: (2020)

Incidence and Prevalence of Polymyalgia Rheumatica (PMR): The Importance of the Epidemiological Context. The Italian Case
por: Manzo, Ciro
Publicado: (2019)

Giant cell arteritis with polymyalgia rheumatica on FDG‐PET/CT
por: Baba, Akira, et al.
Publicado: (2017)

Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica
por: Milchert, Marcin, et al.
Publicado: (2020)

Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients
por: Ramon, André, et al.
Publicado: (2022)

Not just pain and morning stiffness duration in the daily experience of patients with polymyalgia rheumatica. Does the rheumatologist listen to all patient-reported outcomes?
por: Manzo, Ciro, et al.
Publicado: (2021)

Polymyalgia Rheumatica
por: Dixon, A. St J.
Publicado: (1969)

Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021)

Answer to Mungmunpuntipantip et al. “SARS CoV-2 vaccine AND rituximab” Joint Bone Spine 2021;88:105281
por: Verhoeven, Frank, et al.
Publicado: (2022)

Polymyalgia rheumatica with normal inflammatory indices at the time of diagnosis: can we just move a step forward?
por: Manzo, Ciro, et al.
Publicado: (2020)

Giant Cell Arteritis Mimicking Polymyalgia Rheumatica: A Challenging Diagnosis
por: Ohta, Ryuichi, et al.
Publicado: (2022)

Metabolic bone health considerations in giant cell arteritis and polymyalgia rheumatica
por: Low, Candice, et al.
Publicado: (2023)

Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature
por: Manzo, Ciro, et al.
Publicado: (2020)

Absence of Long-Lasting Morning Stiffness at the Time of Diagnosis as Paraneoplastic Warning in Patients with Polymyalgia Rheumatica (PMR): Data from Italian Single-Center Study
por: Manzo, Ciro, et al.
Publicado: (2023)

If something looks like an apple, is it necessarily an apple? – reflections on so-called “statin-induced polymyalgia rheumatica”
por: Manzo, Ciro
Publicado: (2019)

An update on polymyalgia rheumatica
por: Lundberg, Ingrid E., et al.
Publicado: (2022)

Depression and depressive symptoms in patients with polymyalgia rheumatica: discussion points, grey areas and unmet needs emerging from a systematic review of published literature
por: Manzo, Ciro, et al.
Publicado: (2020)

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
por: Emamifar, Amir, et al.
Publicado: (2021)

Polymyalgia rheumatica and remitting seronegative symmetrical synovitis with pitting edema following intravesical instillation of bacillus Calmette-Guerin
por: Manzo, Ciro
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8rrhjgvlesv4c39q94uf714vq0